Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
129,668,560
-
Total 13F shares
-
94,250,581
-
Share change
-
+1,005,249
-
Total reported value
-
$2,602,301,782
-
Put/Call ratio
-
109%
-
Price per share
-
$27.61
-
Number of holders
-
268
-
Value change
-
+$27,489,034
-
Number of buys
-
110
-
Number of sells
-
123
Institutional Holders of NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) as of Q1 2020
As of 31 Mar 2020,
NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) was held by
268 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
94,250,581 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Kopp Family Office, LLC, Invesco Ltd., Artisan Partners Limited Partnership, STATE STREET CORP, JANUS HENDERSON GROUP PLC, BROWN ADVISORY INC, EAGLE ASSET MANAGEMENT INC, and CARILLON TOWER ADVISERS, INC..
This page lists
268
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.